4. Hematology Flashcards
anemia
reduction in 1 of the following:
[Hg]
hct
RBC
WHO anemia definition
Hb < 12 g/dL women
Hb < 13 g/dL men
DLO2
CO*CaO2
CaO2
1.34HbSaO2 + PaO2*0.003
major contributor to amount of O2 in blood
hb
anemia compensation
redistribution of blood from skin/muscles/kidneys to brain heart and lung
shunt of blood from kidneys causes
EPO release
trigger for transfusion
Hb < 10 g/dL
Hct < 30%
in anemic pts we should try to _____ O2-Hb curve
aovid shifting O2-Hb left
CADET face RIGHT
CO2
Acid
D 2,3 DPG
Exercise
Temp
microcytic anemia
MCV < 80fL
microcytic anemia common causes
iron deficiency
thalassemia
iron deficiency causes infants
nutritional deficieny
iron definciency primary cause adults
blood loss
iron deficiency anemia labs
Hb 9-12 g/dL
ferritin < 41 ng/mL
thalassemia diagnosis
Hb electrophoresis
thalaseemia best anesthetic technique
all equal
thalassemia SE
incr thrombotic risk
normocytic anemia
MCV 80-100 fL
normocytic anemia types
hemolytic anemia
chronic disease anemia
CKD anemia
aplastic anemia
normocytic anemias trait
have enough material to make RBCs but RBCs dont last long enough or cant make enough RBCs to keep up
hereditatry spherocytosis
autosomal dominant
deficiency in membran proteins
unable to mx RBC shape
hereditary spheocytosis ahould avoid
mechanical valves
bypass
hereditary elliptocytosis
autosomal dominant abnormalioty of membrane proteins spectrin/glycophorin
elliptical or rod shape
acanthocytosis
defective membrane structure due to lack of beta-lipoprotein
acanthocytosis comorbidities
cirrhosis
severe pancreatitis
paroxysmal nocturnal hymoglobinuria
stem cell disorder in 2nd - 8th decade of life
paroxysmal nocturnal hemoglobinuria S+S
dark urine overnight
paroxysmal nocturnal hemoglobinura treatment
exulizumab
what should you not use in paroxysmal noctunal hemoglobinura
cell saver
Glu-6-phos dehydrogenase deficiency
x-linked genetic disroder
RBC unable to handle stress so hemolysis occurs
Glu-6-phos dehydrogenase definiency avoid
oxidative drugs:
iso
sevo
reglan
penicillin
methylene blue
hypothermia
acidosis
hyperglycemia
what form of iron do we want
Fe2+ (ferrous)
does sickle cell trait cause incr M+M?
no - only sickle cell disease
SCA Hct goal
30%
SCA goals
decr anxiety
hydration
decr acidosis
decr hypothermia
Sickle C
cells lose water thorugh incr K+/Cl- transporter activity
warm autoimmune hemolytic anemia (WAHA)
red cell lysis due to warm agglutinis
IgG lysis at 37C+
WAHA associated with
lupus
lymphoma
leukemia
HIV
Cold autoimmune hemolytic anemia (CAHA)
red cel lysis due to cold exposure
ImM lysis at 0-10C
CAHA associated with
mycoplasma infections
neoplamss
CAHA treatment
avoid cold
rituximab
plasmapheresis
WAHA treatment
corticosteroids
splenectomy
rituximab
anemia of chronic disease (ACD)
decr production
+
decr lifespan of RBCs
ACD type
normocytic
normochromic
hyperproliferative
ACD mech
iron trapped in macrophages
decr [EPO]
ACD treatment
cure underlying dz
give Iron
give EPO
anemia of CKD
due to decr EPO production
ACKD treament
correct iron deficiency
give EPO
ACKD hb goal
Hb 10-12 g/dL
aplastic anemia
autosomal recessive
progressive failure of bone marrow that usually results in leukemia
macrocytic anemia
MCV: >100 fL
defects in nuclear maturation
most common macrocytic anemia
Folate/B-12 deficiency
macrocytic anemia treatment
vitamins
decr alcohol
HbM
ferrous iron oxidized to ferric iron
HbM treatment
methylene blue
1-2 mg/kg over 3-5 mins
polycythemia
incr RBC mass and Hct due to hypoxia-stimulated EPO production
optimal Hct for O2 transport
33-36%
optimal Hb for O2 transport
11-12 g/dL
what happens to blood viscosity at higher Hct/Hb?
incr blood viscosity
decr BF
decr O2 delivery
polycythemia vera
stem cell disorder
JAK2 gene mutation
incr RBC count
+/- incr plt count
+/- incr leukocyte count
polycythemia vera diagnosis
female:
Hb > 16
Hct > 48
male:
Hb > 16.5
Hct > 49
decr serum EPO
polycythemia cera treatment
dilute Hct < 45%
aspirin
myelosuppressive drugs
polycythemia vera risks
thrombosis
hemorrhage
Factor VII deficiency
rare autosomal recessive disease
Factor VII deficiency diagnosis
symptomatic bleeding when levels drop below 15%
Factor VII levels pre-op
20-25%
factor vii bleeding treatment
Factor VII
recombinant (novoseven)
PCC
FFP
Factor X
Factor V
Prothrombin deficiency treatment
FFP (15-20 ml/kg)
PCC (25-50 iu/kg)
FFP dosing
15-20 ml/kg
PCC dosing
25-50 iu/kg
PCC risks
thrombus
thromboembolism
DIC
Factor VIII (hemophilia A) chromosome
x
HemA severe
< 1% factor level
HemA mod
1-5% factor level
HemA mild
6-30% factor level
Haem A diagnosis
prolonged aPTT
normal PT
HemA treatment
factor VIII
DDAVP
emicizumbab
HemA level for major sx
80-100%
HemA level minor sx
50-80%
DDAVP day of surgery
incr F8 3-5x
HemA periop bleeding treatment
FFP
cryo
amicar
TXA
Factor IX deficiency (HemB) severe
<1% factor level
HemB mod
1-5% factor level
HemB mild
5-40% factor level
HemB diagnosis
prolonged aPTT
normal PT
HemB treatment
recombinant F9
F9 PCC
F9 half life
18-24 hrs
F9 infusion repeated
12-24 hrs
F11 deficiency bleeding
mild
F11 treatment
TXA
amicar
Factor Xi concenctrate
where is fibrinogen synthesized
liver (from 3 genes on chromosome 4)
fibrinogenemia treatment
fibrinogen
cryo
cryo dose minor sx
1U / 10kg
cryo dose major sx
1U/5kg
fibrinogen target major sx
> 100 mg/dL
fibrinogen target minor sx
> 50 mg/dL
thrombocytopenia
low plts
plt half life
9-10days
plts per day
15,000-45,000
treatment for bleeding and low plateelets
give platelets
plts for minor sx
20k-30k
plts for maj sx
50k
neuraxial plts
70k-100k
1 unit of plts
incr plts by 50k
do plts need ABO compatibility
no
do plts need RH compatibility
yes
DIC
coagulopathy due to excess intravascular thrombin and widespread clotting and bleeding
DIC states
procoagulant
hyperfibrinolytic
DIC labs
plts
PT
PTT
fibrinogen
D-dimers
thrombotic thrombocytopenia purpura (TTP)
plt rich thrombin in arterial and capillary microvasculatured leading to thrombocytopenia and microangiopathic hemolytic anemia
TTP cause
ADAMTS 13 protease deficiency
TTP treatment
plasma exchange
glucocorticpids
rituxiumab
caplacizuman
should you give plts in TTP
only in life threatening bleeding
- plts can incr thrombosis and organ damage
hemolytic uremic syndrome (HUS)
similar to TTP
caused by E.coli infection
HUS treatment
fluids
RBCs
plts
dialysis w/decr kidney function
HELLP
thrombocytopenia in pregnancy
HELLP characteristics
Hemolysis
Elevated Liver
Low Platelets
HELLP pts can develop _____ post-delivery
TTP
Heparin induced thrombocytopenia (HIT)
immunomediated response
decr plt count caused by heparin binding to plts
HIT treatment
stop heparin
give direct thrombin inhibitor (bivalrudin/dabigatran)
give anti-Xa inhibitor (aban)
give plts
corticosteroids
which drug do you give for recent HIT pts in CABG
bivalrudin
idiopathic thrombocytopenia purpura
not related to drugs, infection or autoimmune
ITP treatment
high dose corticosteroids
plt transfusion
IV immunoglobulin
most common inherited abnormality afffecting plt function
vwD
vwD managment
DDAVP
vwF
TXA
amicar
DDAVP should only be given for Type ___ vwD
Type 1
hypercoagulability
predisposes pts to VTE
hypercoag low risk
early ambulation
hypercoag mod risk
SCDs
early ambulation
hypercoag sev risk
subQ heparin
LMWH